Vitanova Biomedical

Vitanova Biomedical is an early-stage biotechnology company dedicated to providing transformative cancer treatments by utilizing light-activated intracellular acidosis. The company's cancer treatment method, Light-Activated Intracellular Acidosis (LAIA), is based on three recognized principles of cancer therapy: 1) Intracellular acidosis leads to rapid pH-induced cancer cell death. 2) Compounds can be activated by specific wavelengths of light; 3) Antibody-antigen conjugates can selectively target nanoparticles to specific cancer types. VNB’s data supports LAIA effectively inducing early apoptosis in five different cancer cell types, including triple-negative breast cancer, pancreatic cancer, and prostate cancer cells, resulting in 81-100% cancer cell death within less than two hours.